| Price | $1.38 |
| Year Range | $1.28 – $2.94 |
| Market Cap | $261M |
| Industry | Biotechnology |
What Is Century Therapeutics’s AI Stock Analysis?
Century Therapeutics’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks Century Therapeutics’s momentum in near-real time.
Century Therapeutics (IPSC) has an AltIndex AI Score of 49/100, currently a Hold signal. The AI Score distills Century Therapeutics's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.
Century Therapeutics’s Full AI Analysis
Keep reading AltIndex’s full AI analysis of Century Therapeutics — the fundamental, technical and alternative-data breakdown and the recommendation.
Sign up to read the full analysisWhat’s Driving IPSC’s AI Score?
Fundamentals
Net income for the last quarter was $-35M. This represents a decrease of 59.62% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 6.17%, which may be a cause for concern. Ebitda for the last quarter was $-35M. This represents a decrease of 85.20% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 17.67%, which may be a cause for concern. In the last couple of months, there's been a couple of company insiders selling their stock, a potentially bearish signal.
See Century Therapeutics’s earnings and insider transactions.
Technicals
Today's stock price is $1.38. This represents a decrease of 28.87% compared to a month ago, which may be concerning in the short-term. Compared to a year ago, there is an increase of 146.43%, suggesting a positive long-term trend. The trend is bearish. The current SMA10 is $1.43, which is lower than the previous SMA10 of $1.45. This suggests a potential downward trend in price movement. The RSI is 68.8, indicating a neutral condition.
See the full technical analysis and price prediction.
Alternative data
Century Therapeutics has an estimated 3 open positions and this number has been stable over the last couple of months indicating a company in a stable position. Century Therapeutics has an estimate of 4,000 visitors to their webpage. The number of visitors is down by -43% in the last couple of months, a worrisome trend as this can indicate a loss in customers.
Explore Century Therapeutics’s job postings, web traffic and app downloads.
Frequently Asked Questions: Century Therapeutics AI Stock Analysis
Century Therapeutics's AltIndex AI Score is 49/100, currently a Hold signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.
AltIndex's AI Score model rates Century Therapeutics a Hold (49/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.
The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.
AltIndex generates a complete written AI analysis of Century Therapeutics — company overview, fundamentals, technicals and alternative data, with a recommendation. See the IPSC AI Score or sign up to read the full thesis.
